Here's Why HCA Healthcare (HCA) is a Strong Growth Stock

HCA Healthcare, the largest non-governmental operator of acute care hospitals in the U.S., is highlighted as a strong growth stock by Zacks, despite its current #3 (Hold) Rank. The company boasts an 'A' Growth Style Score, supported by a forecasted 18.9% year-over-year earnings growth for the current fiscal year and recent upward revisions by analysts for fiscal 2025 earnings estimates to $26.11 per share. This combination of robust growth metrics and top-tier Style Scores positions HCA as a compelling consideration for investors seeking growth opportunities.

Analysis

HCA Healthcare (HCA) presents a strong growth profile based on forward-looking earnings metrics, despite its current neutral Zacks #3 (Hold) rank. The company scores an 'A' for both its overall VGM and its specific Growth Style Score, underpinned by a forecast for 18.9% year-over-year earnings growth in the current fiscal year. This positive outlook is further substantiated by recent analyst activity for fiscal 2025, where 10 analysts have revised earnings estimates upward, lifting the consensus estimate by $0.83 to $26.11 per share. HCA's operational execution is also notable, with a historical average earnings surprise of +7%, suggesting a consistent ability to outperform expectations. The contradiction between the neutral 'Hold' rating and the highly positive growth indicators suggests that while the stock may not be a 'Strong Buy' based on the full scope of estimate revisions, its fundamental growth trajectory is compelling and may not be fully reflected in its current consensus rating.

Key Decisions for Investors

• Growth-oriented investors should consider HCA's strong quantitative signals, particularly the forecasted 18.9% YoY earnings growth and the top-tier 'A' Growth Score, as indicators of potential upside.
• Monitor for a potential upgrade from the current #3 (Hold) rank, as the recent positive trend in fiscal 2025 earnings estimate revisions could be a leading indicator of improving analyst sentiment.
• Given the company's track record of a +7% average earnings surprise, investors might factor in a higher probability of HCA beating its future earnings estimates when modeling potential returns.